(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.25%) $79.19
(-0.41%) $2.18
(-0.24%) $2 316.70
(-0.13%) $27.57
(0.02%) $984.80
(0.09%) $0.930
(-0.05%) $10.89
(0.08%) $0.800
(0.34%) $91.75
Live Chart Being Loaded With Signals
Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren S, Zincoren, Otorex, Mofloren-D, and Mofloren LP...
Stats | |
---|---|
本日の出来高 | 24 074.00 |
平均出来高 | 105 992 |
時価総額 | 30.80B |
EPS | INR0 ( 2024-01-23 ) |
次の収益日 | ( INR2.80 ) 2024-05-21 |
Last Dividend | INR2.25 ( 2023-09-18 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 30.35 |
ATR14 | INR0.318 (0.10%) |
ボリューム 相関
Indoco Remedies Limited 相関
10 最も正の相関 | |
---|---|
ICICIGI.NS | 0.898 |
RADIOCITY.NS | 0.889 |
INSECTICID.NS | 0.883 |
INDUSTOWER.NS | 0.881 |
HDFCAMC.NS | 0.878 |
SAREGAMA.NS | 0.876 |
IDEA.NS | 0.874 |
PUNJABCHEM.NS | 0.869 |
SHOPERSTOP.NS | 0.866 |
TCIFINANCE.NS | 0.865 |
10 最も負の相関 | |
---|---|
SICAGEN.NS | -0.883 |
SMLT.NS | -0.881 |
OIL.NS | -0.875 |
STAMPEDE.NS | -0.873 |
STERTOOLS.NS | -0.871 |
NEWGEN.NS | -0.871 |
KEERTI.NS | -0.869 |
SURYAROSNI.NS | -0.863 |
ROTO.NS | -0.862 |
PDSMFL.NS | -0.856 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Indoco Remedies Limited 相関 - 通貨/商品
Indoco Remedies Limited 財務諸表
Annual | 2022 |
収益: | INR16.40B |
総利益: | INR11.19B (68.21 %) |
EPS: | INR15.44 |
FY | 2022 |
収益: | INR16.40B |
総利益: | INR11.19B (68.21 %) |
EPS: | INR15.44 |
FY | 2022 |
収益: | INR15.04B |
総利益: | INR10.40B (69.16 %) |
EPS: | INR16.80 |
FY | 2021 |
収益: | INR12.19B |
総利益: | INR8.59B (70.49 %) |
EPS: | INR10.10 |
Financial Reports:
No articles found.
Indoco Remedies Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0.750 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR2.25 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.667 | 2005-09-15 |
Last Dividend | INR2.25 | 2023-09-18 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 21 | -- |
Total Paid Out | INR20.23 | -- |
Avg. Dividend % Per Year | 0.26% | -- |
Score | 1.79 | -- |
Div. Sustainability Score | 2.93 | |
Div.Growth Potential Score | 3.59 | |
Div. Directional Score | 3.26 | -- |
Year | Amount | Yield |
---|---|---|
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR1.000 | 0.52% |
2019 | INR0.300 | 0.14% |
2020 | INR0.300 | 0.16% |
2021 | INR1.500 | 0.49% |
2022 | INR0.750 | 0.17% |
2023 | INR2.25 | 0.55% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RPPL.NS | Dividend Junior | 2023-08-24 | Annually | 6 | 0.31% | |
LIKHITHA.NS | Dividend Junior | 2023-09-20 | Annually | 4 | 0.46% | |
GANESHHOUC.NS | Dividend Junior | 2023-08-31 | Sporadic | 18 | 0.18% | |
APTUS.NS | Dividend Junior | 2023-05-12 | Semi-Annually | 3 | 0.32% | |
TECHNOE.NS | Dividend Junior | 2023-09-15 | Annually | 16 | 1.13% | |
ONGC.NS | Dividend Knight | 2023-08-18 | Semi-Annually | 28 | 4.00% | |
IOC.NS | Dividend Knight | 2023-07-28 | Semi-Annually | 28 | 5.08% | |
CRAFTSMAN.NS | Dividend Junior | 2023-06-19 | Annually | 3 | 0.13% | |
SHANTIGEAR.NS | Dividend Junior | 2023-07-11 | Annually | 23 | 1.02% | |
MANGCHEFER.NS | Dividend Junior | 2023-09-18 | Annually | 17 | 1.18% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0571 | 1.500 | 8.86 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0969 | 1.500 | -0.0350 | -0.0524 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 5.33 | 1.000 | 9.14 | 9.14 | [3 - 30] |
operatingCashFlowPerShareTTM | 14.32 | 2.00 | 5.23 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 14.32 | 2.00 | 2.84 | 5.68 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.691 | 1.000 | 1.820 | 1.820 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.104 | 1.000 | 9.92 | 9.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 30.19 | 1.000 | 7.05 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0969 | 2.50 | -0.0225 | -0.0524 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 14.32 | 2.00 | 5.23 | 5.68 | [0 - 30] |
dividendYielPercentageTTM | 0.676 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 14.32 | 2.00 | 5.23 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.455 | 1.500 | -0.299 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0742 | 1.000 | -0.645 | 0 | [0.1 - 0.5] |
Total Score | 3.59 |
Indoco Remedies Limited
Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur; urology products, such as Carmicide and Cital; Cloben G and Scabex for dermatology; ATM for anti-infectives; Hemsyl for blood related; MCBM 69 and D Chiro for gynecological; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。